| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3204344 | The Journal of Allergy and Clinical Immunology: In Practice | 2013 | 7 Pages |
Abstract
This analysis showed that consistent omalizumab treatment was associated with significant reductions in ED visits and hospitalizations.
Keywords
PDCOCsICSSABALong-acting β2-agonistsShort-acting β2-agonistsClaims dataOmalizumabemergency departmentHospitalizationsResource utilizationAdherenceAsthma treatmentemergency department visitsLABAInternational Classification of Diseases, Ninth RevisionPersistencehazard ratioproportion of days coveredAsthma controlInhaled corticosteroidsoral corticosteroids
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Marie-Hélène MA, Jonathan MSc, Jie PhD, Boris PharmD, Maria PhD, Patrick MA,